Tag Archives: AbbVie

EHA: AbbVie, Roche cement Venclexta’s place in AML with survival win

AbbVie and Roche’s Venclexta has struggled to significantly prolong acute myeloid leukemia (AML) patients’ lives when coupled with a certain type of chemo. But not azacitidine. Adding Venclexta to azacitidine slashed the risk of death by 34% among previously untreated patients, the partners said Saturday at the European Hematology Association’s virtual annual congress. Patients taking… Read More »

AbbVie, Allergan merger may face regulatory delay due to COVID-19: report

With the final hurdle for their $ 63 billion merger cleared in the EU, AbbVie and Allergan were in the home stretch to close the deal. Then the novel coronavirus took off, and now that merger could be further out of reach as regulatory bodies prepare to pump the brakes.  AbbVie and Allergan’s pending merger may face… Read More »

AbbVie nears Allergan lockup with EU antitrust approval—and only one selloff required

AbbVie and Allergan have waited expectantly to seal the deal on their $ 63 billion merger as international watchdogs took a close look at the combo. Now, they’re almost home free. The EU says it’s prepared to give a green light to the deal—and a positive view from U.S. regulators could soon follow. The European Commission approved… Read More »